These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 29625557)

  • 1. Case report: lactic acidosis and rhabdomyolysis during telbivudine and tenofovir treatment for chronic hepatitis B.
    Ying Y; Hu YK; Jin JL; Zhang JM; Zhang WH; Huang YX
    BMC Gastroenterol; 2018 Apr; 18(1):45. PubMed ID: 29625557
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rhabdomyolysis, lactic acidosis, and multiple organ failure during telbivudine treatment for hepatitis B: a case report and review of the literature.
    Zheng J; Deng M; Qiu X; Chen Z; Li D; Deng X; Deng Q; Yu Z
    J Med Case Rep; 2017 Nov; 11(1):331. PubMed ID: 29179767
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lactic acidosis during telbivudine treatment for HBV: a case report and literature review.
    Jin JL; Hu P; Lu JH; Luo SS; Huang XY; Weng XH; Zhang JM
    World J Gastroenterol; 2013 Sep; 19(33):5575-80. PubMed ID: 24023503
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extrahepatic effects of nucleoside and nucleotide analogues in chronic hepatitis B treatment.
    Fung J; Seto WK; Lai CL; Yuen MF
    J Gastroenterol Hepatol; 2014 Mar; 29(3):428-34. PubMed ID: 24372662
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Continuous venovenous hemodiafiltration for hyperlactatemia caused by telbivudine in a patient with chronic hepatitis B: a case report and update review.
    Wang YH; Wu BQ; Liu H
    J Dig Dis; 2015 Mar; 16(3):164-7. PubMed ID: 25043654
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Telbivudine-induced rhabdomyolysis in a patient undergoing haemodialysis: A case report and review of literature.
    Wu K; Xu X; Huang L; Zhu E; Dong Y; Zhang Z; Yan X; Zhang Y
    J Int Med Res; 2023 Dec; 51(12):3000605231222244. PubMed ID: 38140948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 52-week efficacy and safety of telbivudine with conditional tenofovir intensification at week 24 in HBeAg-positive chronic hepatitis B.
    Piratvisuth T; Komolmit P; Tanwandee T; Sukeepaisarnjaroen W; Chan HL; Pessôa MG; Fassio E; Ono SK; Bessone F; Daruich J; Zeuzem S; Cheinquer H; Pathan R; Dong Y; Trylesinski A
    PLoS One; 2013; 8(2):e54279. PubMed ID: 23390496
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Telbivudine myopathy in a patient with chronic hepatitis B.
    Wang M; Da Y; Cai H; Lu Y; Wu L; Jia J
    Int J Clin Pharm; 2012 Jun; 34(3):422-5. PubMed ID: 22527478
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Successful Treatment of Tenofovir Alafenamide-Induced Lactic Acidosis: A Case Report.
    Arnouk S; Whitsett M; Papadopoulos J; Stewart Lewis Z; Dagher NN; Feldman DM; Park JS
    J Pharm Pract; 2023 Oct; 36(5):1260-1263. PubMed ID: 35635046
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Review article: nucleos(t)ide analogues in patients with chronic hepatitis B virus infection and chronic kidney disease.
    Pipili C; Cholongitas E; Papatheodoridis G
    Aliment Pharmacol Ther; 2014 Jan; 39(1):35-46. PubMed ID: 24299322
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Two cases of telbivudine-induced myopathy in siblings with chronic hepatitis B.
    Kim EH; Park H; Lee KH; Ahn SH; Kim SM; Han KH
    Clin Mol Hepatol; 2013 Mar; 19(1):82-6. PubMed ID: 23593614
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of sequential use of telbivudine in hepatitis B e antigen-positive chronic hepatitis B patients with partial responses to pegylated interferon: a pilot study.
    Huang Z; Zhao Z; Zheng Y; Peng L; Lin C; Deng H; Gao Z
    J Viral Hepat; 2013 Apr; 20 Suppl 1():52-7. PubMed ID: 23458525
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Telbivudine plus pegylated interferon alfa-2a in a randomized study in chronic hepatitis B is associated with an unexpected high rate of peripheral neuropathy.
    Marcellin P; Wursthorn K; Wedemeyer H; Chuang WL; Lau G; Avila C; Peng CY; Gane E; Lim SG; Fainboim H; Foster GR; Safadi R; Rizzetto M; Manns M; Bao W; Trylesinski A; Naoumov N
    J Hepatol; 2015 Jan; 62(1):41-7. PubMed ID: 25152207
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HBeAg Seroconversion in HBeAg-Positive Chronic Hepatitis B Patients Receiving Long-Term Nucleos(t)ide Analog Treatment: A Systematic Review and Network Meta-Analysis.
    Xing T; Xu H; Cao L; Ye M
    PLoS One; 2017; 12(1):e0169444. PubMed ID: 28107377
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Telbivudine plus tenofovir in combination therapy in patients with chronic hepatitis B infection--an Indian experience.
    Panda C
    J Assoc Physicians India; 2013 Nov; 61(11):785-8. PubMed ID: 24974488
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fatal lactic acidosis in hepatitis B virus-associated decompensated cirrhosis treated with tenofovir: A case report.
    Jung TY; Jun DW; Lee KN; Lee HL; Lee OY; Yoon BC; Choi HS
    Medicine (Baltimore); 2017 Jun; 96(25):e7133. PubMed ID: 28640087
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of switching to telbivudine plus adefovir in suboptimal responders to lamivudine plus adefovir.
    Park H; Park JY; Kim SU; Kim DY; Han KH; Chon CY; Ahn SH
    World J Gastroenterol; 2013; 19(43):7671-9. PubMed ID: 24431895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Viral infection parameters not nucleoside analogue itself correlates with host immunity in nucleoside analogue therapy for chronic hepatitis B.
    Li CZ; Hu JJ; Xue JY; Yin W; Liu YY; Fan WH; Xu H; Liang XS
    World J Gastroenterol; 2014 Jul; 20(28):9486-96. PubMed ID: 25071343
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of telbivudine therapy in liver failure patients with chronic hepatitis B virus infection.
    Wang L; Chen H; Fan C; Gong Z
    J Med Virol; 2013 Nov; 85(11):1907-12. PubMed ID: 23852947
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of entecavir, tenofovir and telbivudine treatment on renal functions in chronic hepatitis B patients.
    Kara AV; Yıldırım Y; Ozcicek F; Aldemir MN; Arslan Y; Bayan K; Çelen MK
    Acta Gastroenterol Belg; 2019; 82(2):273-277. PubMed ID: 31314188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.